Infiuss Health · Oct 2025
Describes Infiuss's Digital Patient Twin approach, trial simulation workflows, and how it integrates with PROBE CTMS and other systems.
2 sided Marketplace for accelerating medical research
Company research
Public company, workplace, funding, and market signals
Overview
Infiuss Health is a Buffalo-based, remote-first clinical research SaaS/CRO focused on Africa. Its Probe and Digital Patient Twin platform helps sponsors simulate trial design, recruit participants, and run decentralized or hybrid studies. Public sources disagree on some historical details (especially founding year and capital raised), so I’ve used the company site and other public pages where possible and left uncertain items null or conservative.
Primary product
Probe, an AI-powered Digital Patient Twin / clinical trial management platform for remote and decentralized clinical research
Founded
2021
Headquarters
1 Seneca Street, Buffalo, New York 14203, United States
Team size
1-10
Work style
Remote
Industry
Technology, Information and Internet
Sub-industry
Clinical trial software / decentralized clinical research
Offices
1 Seneca Street, Buffalo, New York 14203, United States (HQ)
San Francisco, California, United States
Lagos, Nigeria
Cameroon
Business model
B2B SaaS
CRO / clinical research services
patient recruitment services
clinical trial data management
data aggregation / licensing
enterprise services / concierge support
Funding
Stage
venture-backed
Total raised
$4.4M
Latest round
Venture Round · Sep 2022
Latest amount
$2.5M
People & investors
Leadership
CEO and Founder
Interim Head of Product & Engineering; Co-founder & Technical Lead
Head of Research Division
Work & culture
Mission-driven, remote-first, global team culture with a strong emphasis on flexibility, learning, and distributed collaboration.
Work style
Remote
Compensation
Public compensation signals are limited; one public role advertised $110,000-$150,000, but there is no company-wide compensation policy disclosed publicly.
Benefits
Global team
Remote-first
Flexible working hours
Career growth
Professional development plan
Yearly learning budget
Regular company-wide retreats
Flexible vacation policy
Unlimited time off
Product & market
Pricing
Custom quote / project-based B2B services and enterprise CRO contracts; no public self-serve pricing was found.
Differentiators
- —Africa-focused decentralized clinical research and CRO offering
- —Digital Patient Twin simulation for RCT design and protocol optimization
- —Probe platform combines recruitment, CTMS/CDMS, and patient engagement
- —Access to diverse African participant populations and data
- —Remote and hybrid study execution with local clinics/labs/mobile professionals
- —Therapeutic focus on infectious disease, oncology, and dermatology
Technology
AI/ML
Large language models
Digital Patient Twin modeling
Probe CTMS/CDMS
HL7 FHIR
DICOM
Laravel
Vue
Nuxt
HIPAA compliance
GDPR compliance
SOC 2 Type II
ISO 27001
Customers
Ananya Health
Elythea
MHRA
Digistain
Kenyatta National Hospital
Bertoua District Hospital
Ghana Health Service
Cameroon Ministry of Health
pharmaceutical companies
academic researchers
Competitors
Evidation
myTomorrows
Antidote
mfine
Ready
Scale & contact
Estimated revenue
~$440K ARR (GetLatka estimate, updated 2025-09-02)
Estimated monthly visits
44.8K
Traffic estimate as of Jul 2026
Latest news
Infiuss Health · Sep 2025
Discusses Infiuss's own digital-twin stack, multi-layer data aggregation, and model selection approach for healthcare AI.
Infiuss Health · Aug 2025
A technical founder-oriented guide on choosing models, budgeting, compliance, and product decisions for AI healthcare products.
Infiuss Health · Nov 2024
Explains how Infiuss is using AI to speed participant recruitment, improve trial design, and analyze clinical data for more inclusive and efficient trials.
Infiuss Health · Dec 2023
Covers Infiuss's perspective on curated healthcare datasets, diversity, and secure data access for AI training.
Jobs and careers at Infiuss Health
0 jobs at Infiuss Health
No open positions
Check back later for new openings